Liver Diseases Clinical Trial
Official title:
Repeatability and Reproducibility of Quantitative MRCP
This study aims to determine the repeatability and reproducibility of Quantitative Magnetic
Resonance Cholangiopancreatography (MRCP).
Imaging scientists at Perspectum Diagnostics have developed a hessian-based mathematical
model to enhance conventional MRCP to a 3D geometric model of the biliary tree, 'Quantitative
MRCP'. This enables advanced quantitative measurement of bile duct width, orientation,
branching point and curvative metrics.
The technology has been validated against 3D printed phantoms for accuracy, and early
clinical research has demonstrated the technology has potential for clinical impact, with
improvement in radiologist performance versus conventional non-enhanced MRCP imaging (Vikal
et al 2017).
Quantitative MRCP aims to act as a tool to not only improve assessment of the current status
of the biliary tree, but also act as a mechanism to track change within the ducts. Thus, it
must be established that any change between scans is due to change in the physiology of the
individual and not due to a quirk or fault of the technology.
In order to achieve this a series of scans will be performed on an individual over a short
period of time, for which the condition of the biliary tree within that individual can be
assumed to be constant. Between each scan, subject and coil repositioning will occur.
The study will recruit a group of adult volunteers, from both diseased groups and healthy
groups in order to achieve a range of physiological biliary metrics.
Biliary-related conditions, such as autoimmune conditions Primary Biliary Cholangitis (PBC),
and Primary Sclerosing Cholangitis (PSC), and also cancers such as cholangiocarcinoma, affect
tens of thousands of individuals in the UK each year. All biliary conditions require careful
tracking of the structure and integrity of the biliary tree so that intervention can be
carefully planned and with that, outcomes improved.
The current non-invasive gold-standard for assessment of the biliary tree is MRI-based
Magnetic Resonance Cholangiopancreatography (MRCP). This method uses no contrast and takes up
to 10 minutes to obtain within a normal scan event. However, there are several limitations to
its use which include, images having great variability in quality and are used mainly for
qualitative analysis. Using conventional MRCP a consultant can, depending on image quality;
identify key structures, inform diagnosis, and give a general assessment on the health of the
biliary tree structure. However, current MRCP imaging only allows limited quantitative
assessment of the ducts. More extensive, objective quantification has the potential to
dramatically improve the usability of MRCP imaging.With this in mind, imaging scientists at
Perspectum Diagnostics have developed a hessian-based mathematical model to enhance
conventional MRCP to a 3D geometric model of the biliary tree, 'Quantitative MRCP'. This
enables quantitative measurement of bile duct width, orientation, branching point and
curvative metrics.
The technology has been validated against 3D printed phantoms for accuracy, and early
clinical research has demonstrated the technology has potential for clinical impact, with
improvement in radiologist performance versus conventional non-enhanced MRCP imaging (Vikal
et al 2017). Thus, further research into the technology and its viability as an enhancement
to current procedure is necessary if it is to replace conventional MRCP as the primary method
of non-invasive biliary assessment.
Integral to the development of any new technology, is demonstration of the repeatability and
reproducibility of the method. This is the inter-examination variability in results.
Quantitative MRCP aims to act as a tool to not only improve assessment of the current status
of the biliary tree, but also act as a mechanism to track change within the ducts. Thus, it
must be established that any change between scans is due to change in the physiology of the
individual and not due to a quirk or fault of the technology.
The above will be tested by a series of scans performed on an individual over a short period
of time, for which the condition of the biliary tree within that individual can be assumed to
be constant. Between each scan, subject and coil repositioning will occur. The study will
recruit a group of adult volunteers, from both diseased groups and healthy groups in order to
achieve a range of physiological biliary metrics.
Quantitative MRCP is an MRI based method, requiring no contrast, however consuming a drink
containing manganese improves the quality of MRCP images significantly (Frisch et al., 2017),
and therefore patients are routinely asked to drink pineapple juice (naturally high in
manganese) before having a clinical MRCP scan. At present, multiparametric MRI to assess the
health of liver tissue is performed in a fasted state (Banerjee et al., 2014), however, in
order to offer a comprehensive liver scan including both MRCP and multiparametric MRI in the
same scan, it is important to understand whether consuming pineapple juice will affect the
multiparametric MRI measurements of cT1, PDFF and T2*.
MRI is safe and non-invasive, with no known risks to patients as long as they are
appropriately screened to ensure they have no contraindications to MRI (e.g.pacemaker, metal
implant that is not certified as MR-safe).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05255042 -
Tissue Models for Liver Disease
|
||
Completed |
NCT04473482 -
Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial
|
N/A | |
Not yet recruiting |
NCT05120557 -
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH
|
N/A | |
Completed |
NCT02917408 -
Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
|
||
Recruiting |
NCT03773887 -
Comparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease
|
N/A | |
Recruiting |
NCT00345930 -
DILIN - Prospective Study
|
||
Completed |
NCT00148031 -
Improving Hepatitis C Treatment in Injection Drug Users
|
Phase 4 | |
Terminated |
NCT00031135 -
Total Parenteral Nutrition-Associated Liver Disease
|
Phase 2 | |
Completed |
NCT00005305 -
Hepatitis Delta Infections in Hemophiliacs
|
N/A | |
Completed |
NCT00005304 -
Delta Hepatitis and Liver Disease in Hemophiliacs
|
||
Completed |
NCT00222664 -
Qidong Hepatitis B Intervention Study
|
Phase 4 | |
Recruiting |
NCT06195917 -
Robotic-assisted Percutaneous Transhepatic Puncture
|
N/A | |
Recruiting |
NCT04551742 -
Social & Contextual Impact on Children Undergoing Liver Transplantation
|
||
Completed |
NCT04782050 -
Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation
|
N/A | |
Completed |
NCT03614039 -
Effect of Probiotic and Smectite Gel on NAFLD
|
N/A | |
Recruiting |
NCT04518852 -
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC
|
Phase 2 | |
Recruiting |
NCT05499585 -
Treating Pediatric NAFLD With Nutrition
|
N/A | |
Terminated |
NCT03396705 -
Liver Regeneration
|
||
Completed |
NCT04341012 -
Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases
|
||
Recruiting |
NCT05733832 -
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
|
N/A |